Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Disposition to Issuer of 6 SNGX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | SOLIGENIX, INC. (SNGX) | Disposition to Issuer | 6 | n/a |
| Sep 18, 2026 | SOLIGENIX, INC. (SNGX) | Grant/Award | 78,947 | n/a |
| Jun 4, 2026 | Kura Oncology, Inc. (KURA) | Grant/Award | 35,000 | n/a |
| Jan 15, 2026 | Celularity Inc (CELU) | Grant/Award | 30,000 | n/a |
| Dec 30, 2025 | Celularity Inc (CELU) | Grant/Award | 125,000 | n/a |
| Dec 22, 2025 | Celularity Inc (CELU) | Grant/Award | 67,416 | n/a |
| Nov 21, 2025 | Celularity Inc (CELU) | Grant/Award | 61,539 | n/a |
| Jun 20, 2025 | SOLIGENIX, INC. (SNGX) | Grant/Award | 17,647 | n/a |
| Jun 6, 2025 | Kura Oncology, Inc. (KURA) | Grant/Award | 28,500 | n/a |
| Jan 7, 2025 | Celularity Inc (CELU) | Grant/Award | 67,416 | n/a |